Will transparency lower drug prices, Congress lawmakers ask
Skip to main content
Sister Publication Links
  • Modern Healthcare Metrics
MDHC_Logotype_white
Subscribe
  • Subscribe
  • Register
  • Login
  • News
    • This Week's News
    • Providers
    • Insurance
    • Government
    • Finance
    • Technology
    • Safety & Quality
    • People
    • Regional News
    • Digital Edition
    • House GOP leaders introduce drug-pricing bill to counter Pelosi plan
      IHI releases principles to improving patient safety measures
      Plan members unlikely to benefit from Supreme Court risk corridor battle
      Connecticut tentatively resolves hospital spat over taxes
    • Not-for-profit hospitals stabilized by Medicare pay raise, DSH cut delays
      November was healthcare's second strongest hiring month of 2019
      Primary-care provider ChenMed to enter five new markets
      Lacking specialist access drives health disparities
    • Plan members unlikely to benefit from Supreme Court risk corridor battle
      Joan Budden
      Q&A: Priority Health CEO eager to share best practices with Total Health Care
      Silver-loading, CSR elimination lowered premiums for some rural enrollees
      Centene to sell Illinois plan to CVS Health
    • Capitol Building with pills
      Week Ahead: House to vote on drug bill; SCOTUS hears risk-corridor case
      MedPAC thinks hospice payments are too high
      MedPAC says ambulatory surgical centers don't need a pay raise
      States focus on healthcare costs to address coverage problems
    • Analysts to CommonSpirit Health: Show us the savings
      Smallest hospitals saw biggest earnings gains last month
      Sutter Health postpones financial filing
      doctor helping patient stock image Sandoz
      Sponsored Content Provided By Sandoz
      As hospital executives look to reduce costs, biosimilars offer a compelling option
    • astronaut
      Astronauts developed bloodstream issues in space
      Sponsored Content Provided By ABM Healthcare
      Protecting and Maintaining Medical Devices
      human hand robotic hand stock image
      Sponsored Content Provided By Deloitte
      The Health System of the Future: How Digital Health Technology is Transforming Care
      EHR
      EHR vendors most in-use throughout Medicare incentive program
    • IHI releases principles to improving patient safety measures
      MRIs of dense breasts find more cancer but also false alarms
      Flu season takes off quickly in Deep South states
      Uber driver says South Carolina hospital dumped patient on him
    • Trinity Health appoints new COO: Ben Carter
      Jim Allison playing the harmonica
      Documentary tells tale of Nobel winning researcher
      Seema Verma
      Seema Verma's bold initiatives land her in No. 1 Most Influential spot
      New CEO takes the helm at Lurie Children's Hospital of Chicago
    • Midwest
    • Northeast
    • South
    • West
  • Special Features
    • Best Practices
    • InDepth Special Reports
    • Innovations
    • Chest x-ray from a patient with a vaping-related lung injury
      Vaping-related cases lead to care guidelines from Intermountain
      Arkansas Children’s was a founding partner in Solutions for Patient Safety.
      Children's hospitals collaborate rather than compete on patient safety
      Peer recovery specialists at St. Barnabas Medical Center work with nurse Brenna Zarra.
      Peer recovery helping patients with addiction seek treatment
      UNC Health Care trains staff to treat dementia patients
    • Linda Kenney
      Patient advocate recalls two medical errors that nearly killed her
      Dr. Mark Chassin
      One-size-fits-all approach to patient safety improvement won’t get us to the ultimate goal—zero harm
      Betsy Lehman
      Recent safety scandals suggest healthcare leaders haven't learned lessons
      Doctors and nurse with patient
      20 years after 'To Err is Human,' hospital care quality measures are still of little use
    • Advanced ICU Care
      Telemedicine helps rural hospitals meet intensivist shortage
      Randy Oostra, CEO of ProMedica
      HCR ManorCare deal laid foundation for ProMedica’s growth
      Paging Dr. Robot: Artificial intelligence moves into care
      A child being screened for vision problems using a smartphone.
      App screens kids for eye problems before they can talk
  • Transformation
    • Patients
    • Operations
    • Care Delivery
    • Payment
    • ProMedica doubles down on social needs data analysis
      Amazon taps first pharmacy for Alexa Rx management
      Trump administration unveils new price transparency rules
      A child being screened for vision problems using a smartphone.
      App screens kids for eye problems before they can talk
    • VA dives into artificial intelligence R&D
      Home health to pare down therapy services, up telehealth offerings
      Amazon launches medical transcription service
      Hospitals' uncompensated care continues to rise
    • Chest x-ray from a patient with a vaping-related lung injury
      Vaping-related cases lead to care guidelines from Intermountain
      Advanced ICU Care
      Telemedicine helps rural hospitals meet intensivist shortage
      Peer recovery specialists at St. Barnabas Medical Center work with nurse Brenna Zarra.
      Peer recovery helping patients with addiction seek treatment
      UNC Health Care trains staff to treat dementia patients
    • Value-based pay still struggles to improve costs, quality
      Hospitals sue HHS over negotiated price disclosure rule
      Bundled payments get a boost in two states with employee programs
      CMS wants primary-care docs to take on financial risk
  • Data/Lists
    • Rankings/Lists
    • Data Points
    • Modern Healthcare Metrics
  • Op-Ed
    • Bold Moves
    • Breaking Bias
    • Commentaries
    • Letters
    • Vital Signs Blog
    • From the Editor
    • Randy Oostra, CEO of ProMedica
      HCR ManorCare deal laid foundation for ProMedica’s growth
      Steve Strongwater
      How Atrius Health stayed independent by not shying away from risk
      Why moving the VA to a new EHR was a pivotal decision
      Why AdventHealth's rebrand was more than a name change
    • Terry Shaw
      A diverse and inclusive culture should empower others
      Paving the path to diversity and inclusion
      The next step in healthcare evolution
      Breaking Bias: A road map to boost women and minorities into healthcare leadership
    • Dr. Richard Snyder
      Outdated privacy laws hinder coordinated care, especially in the fight against addiction
      David Dill and Keith Myers
      Healthcare partnerships are a proven path to better care, healthier communities
      Health systems need to devote more resources to caring for the caregivers
      Chip Kahn and Alan Morgan
      Rural healthcare needs innovation, policy changes to survive
    • Letters: Let’s keep humanity in discussions about patient safety
      Hospital with money
      Letters: Let providers set their prices,
 and then publish them all
      Letters: Ambulatory surgery centers aren't getting a break on regulation
      Letters: Rising Medicaid spending isn't a windfall for providers
    • Sponsored Content Provided By Optum
      How blockchain could ease frustration with the payment process
      Sponsored Content Provided By Optum
      Three steps to better data-sharing for payer and provider CIOs
      Sponsored Content Provided By Optum
      Reduce total cost of care: 6 reasons why providers and payers should tackle the challenge together
      Sponsored Content Provided By Optum
      Why CIOs went from back-office operators to mission-critical innovators
  • Awards
    • Nominate
    • Award Programs
    • Previous Award Programs
    • Other Award Programs
    • Nominations Open - Top 25 Minority Leaders
      Nominations Open - Health Care Hall of Fame
    • 100 Most Influential People
    • 50 Most Influential Clinical Executives
    • Best Places to Work in Healthcare
    • Health Care Hall of Fame
    • Healthcare Marketing Impact Awards
    • Top 25 Emerging Leaders
    • Top 25 Innovators
    • Top 25 Minority Leaders
    • Top 25 Women Leaders
    • Excellence in Nursing Awards
    • Design Awards
    • Top 25 COOs in Healthcare
    • 100 Top Hospitals
    • ACHE Awards
  • Events
    • Conferences
    • Galas
    • Webinars
    • Kronos webinar logo lockup
      Sponsored Content Provided By Kronos
      Webinar: The Future of Work in Healthcare
    • Leadership Symposium
    • Healthcare Transformation Summit
    • Critical Connections: Social Determinants of Health Symposium
    • Women Leaders in Healthcare Conference
    • Workplace of the Future Conference
    • Strategic Marketing Conference
    • Health Care Hall of Fame Gala
    • Top 25 Women Leaders Gala
    • Best Places to Work Awards Gala
    • Top 25 Minority Leaders Gala (2020)
  • MORE +
    • Advertise
    • Media Kit
    • Newsletters
    • Jobs
    • People on the Move
    • Reprints & Licensing
MENU
Breadcrumb
  1. Home
  2. Politics & Policy
May 21, 2019 05:03 PM

House lawmakers question whether transparency would fix drug prices

Susannah Luthi
  • Tweet
  • Share
  • Share
  • Email
  • More
    Print
    Getty Images

    Transparency is Washington's buzzword du jour in regards to healthcare, but its limitations were evident Tuesday in a House committee hearing on drug prices.

    As the House Energy and Commerce health panel met to discuss yet another slate of drug-related proposals, pharma and pharma benefit managers tried to negotiate how much financial information they would need to disclose. Meanwhile pharma critics warned that transparency alone won't fix the price problem.

    Most of the seven bills under consideration were aimed at getting manufacturers' justifications for their price hikes, or revealing the obscure negotiations between pharmacy benefit managers, insurers and drugmakers.

    But some Republican lawmakers were clearly uncomfortable with some of these bipartisan proposals, echoing criticisms from the Pharmaceutical Research and Manufacturers of America and an allied witness that the measures could burden companies and even compromise pharmaceutical trade secrets.

    Kristin Bass, chief policy and external affairs officer of the Pharmaceutical Care Management Association, which represents PBMs, didn't want company-specific negotiations to be made public, arguing that it could jeopardize negotiations with manufacturers. Bass also defended the practice of PBMs pushing higher list-price drugs in their formularies, drawing higher rebates.

    Another witness, the conservative economist Douglas Holtz-Eakin, who has ties to the pharmaceutical industry, warned that some of the proposed reporting requirements would burden manufacturers without guaranteeing they would lower prices.

    These arguments drove an exasperated Rep. Peter Welch (D-Vt.) to advocate outright for government negotiation of prices. He has long been pushing for some kind of negotiation measure to give the government means to lower costs. He said the reason lawmakers are talking about transparency measures is because everyone's frustrated with the secretiveness of the system and the high prices that they don't understand.

    "What it reflects is the frustration that states and payers are having, to try to get some grip on why they're getting hammered every year," he said.

    On negotiation, and the potential power of formularies to force negotiation, Welch reminded the panel that formularies already exist but that they "are not for the benefit of the public but of the PBMs."

    Answering Holtz-Eakin's criticism that "I don't think transparency in the end is going to deal with the places where we have high drug prices," Welch asked whether he would support negotiation.

    While Holtz-Eakin made it clear he would not, two other panel witnesses—Frederick Isasi, executive director of the patient advocacy group Families USA, and Mark Miller, executive vice president of healthcare for Arnold Ventures—urged lawmakers to go further than transparency.

    "Is it just transparency or is it transparency with teeth?" Isasi said. "The government needs to say: This is not a fair price; we will not pay it. We have to combine both these things together."

    Welch's frustration reflects the growing restlessness among lawmakers who want serious pricing reforms as time is running out for Congress' legislative push on costs.

    House Speaker Nancy Pelosi (D-Calif.) has yet to unveil the Democratic leadership plan that has been in the works but under wraps for months as her office negotiates with White House officials.

    Meanwhile, Energy and Commerce Health Subcommittee Chair Anna Eshoo (D-Calif.) told witnesses on Tuesday that lawmakers would consider their testimony and recommendations about the proposed bills.

    One of the measures that got significant industry pushback would make drugmakers give 30-days' notice to the HHS secretary before raising certain drug prices as well as justify price hikes with reports of research and development spending, revenue and profits. Bill authors Reps. Jan Schakowsky (D-Ill.) and Tom Rooney (R-Fla.) propose a $100,000 penalty for each day a manufacturer doesn't comply.

    Another measure by Reps. Steven Horsford (D-Nev.) and Tom Reed (R-N.Y.), would require manufacturers to justify their wholesale acquisition cost hikes above certain thresholds, or a price that is $26,000 or more for a year's supply of a drug or for a course of treatment. The CMS would publish a summary of their reasoning for the increases.

    Two additional bills dealt with PBM reporting: under the Public Disclosure of Drug Discounts Act by Reps. Abigail Spanberger (D-Va.), Jodey Arrington (R-Texas) and Brendan Boyle (D-Pa.), PBMs would have to report the aggregate totals of rebates, discounts and price concessions they have negotiated with drugmakers, and then publish the information.

    A proposal by Reps. Jerry Nadler (D-N.Y.) and Doug Collins (R-Ga.) would task the Federal Trade Commission with studying potentially anti-competitive behavior in the PBM industry, including patient steering or favoring higher list-price drugs in their formularies.

    While Bass from the Pharmaceutical Care Management Association said PBMs support aggregate reporting, the ongoing dispute between manufacturers and PBMs was clear when PhRMA Senior Vice President of Policy and Research Lisa Joldersma said Congress should also require reporting of the administrative fees that manufacturers pay PBMs.

    "It seems to be that PBMs double-dip—through rebates, negotiations, and the administrative fees," said Rep. Kurt Schrader (D-Ore.) "It seems a little inappropriate."

    Letter
    to the
    Editor

    Send us a letter

    Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

    Recommended for You
    Sponsored Content
    Get Free Newsletters

    Sign up for free enewsletters and alerts to receive breaking news and in-depth coverage of healthcare events and trends, as they happen, right to your inbox.

    Subscribe Today

    The weekly magazine, websites, research and databases provide a powerful and all-encompassing industry presence. We help you make informed business decisions and lead your organizations to success.

    Subscribe
    Connect with Us
    • LinkedIn
    • Twitter
    • Facebook
    • RSS
    • Instagram

    Stay Connected

    Join the conversation with Modern Healthcare through our social media pages

    MDHC_Logotype_white
    Contact Us

    (877) 812-1581

    Email us

     

    Resources
    • Contact Us
    • Advertise with Us
    • Ad Choices Ad Choices
    • Sitemap
    Editorial Dept
    • Submission Guidelines
    • Code of Ethics
    • Awards
    • About Us
    Legal
    • Terms and Conditions
    • Privacy Policy
    Modern Healthcare
    Copyright © 1996-2019. Crain Communications, Inc. All Rights Reserved.
    • News
      • This Week's News
      • Providers
      • Insurance
      • Government
      • Finance
      • Technology
      • Safety & Quality
      • People
      • Regional News
        • Midwest
        • Northeast
        • South
        • West
      • Digital Edition
    • Special Features
      • Best Practices
      • InDepth Special Reports
      • Innovations
    • Transformation
      • Patients
      • Operations
      • Care Delivery
      • Payment
    • Data/Lists
      • Rankings/Lists
      • Data Points
      • Modern Healthcare Metrics
    • Op-Ed
      • Bold Moves
      • Breaking Bias
      • Commentaries
      • Letters
      • Vital Signs Blog
      • From the Editor
    • Awards
      • Nominate
      • Award Programs
        • 100 Most Influential People
        • 50 Most Influential Clinical Executives
        • Best Places to Work in Healthcare
        • Health Care Hall of Fame
        • Healthcare Marketing Impact Awards
        • Top 25 Emerging Leaders
        • Top 25 Innovators
        • Top 25 Minority Leaders
        • Top 25 Women Leaders
      • Previous Award Programs
        • Excellence in Nursing Awards
        • Design Awards
        • Top 25 COOs in Healthcare
      • Other Award Programs
        • 100 Top Hospitals
        • ACHE Awards
    • Events
      • Conferences
        • Leadership Symposium
        • Healthcare Transformation Summit
        • Critical Connections: Social Determinants of Health Symposium
        • Women Leaders in Healthcare Conference
        • Workplace of the Future Conference
        • Strategic Marketing Conference
      • Galas
        • Health Care Hall of Fame Gala
        • Top 25 Women Leaders Gala
        • Best Places to Work Awards Gala
        • Top 25 Minority Leaders Gala (2020)
      • Webinars
    • MORE +
      • Advertise
      • Media Kit
      • Newsletters
      • Jobs
      • People on the Move
      • Reprints & Licensing